Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. There are no changes to the displayed study details or page content.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:39.000Z thumbnail image
  2. Check
    19 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.4.2' was added. The deletions remove an operating-status notice and a prior revision tag ('Revision: v3.4.1'), which are administrative updates and do not change study content.
    Difference
    0.4%
    Check dated 2026-02-11T10:55:04.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:06.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    UI and metadata updates are minor: a glossary toggle is now shown, the Last Update Submitted that Met QC Criteria label is displayed, a No FEAR Act Data link is included, and the site revision is updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:11:51.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Minor revision from v3.3.3 to v3.3.4 with no detectable changes to study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:58.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a top-level Locations section listing Illinois, Maryland, and Texas, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T20:19:23.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.